Biomolecules & biomedicine

ERBB4 as a treatment target in aortic dissection and its role in cell therapies for blood vessel repair

Updated

Abstract

ERBB4 knockdown significantly inhibited cell viability, migration, proliferation, and angiogenesis in human aortic smooth muscle cells.

  • Differentially expressed genes highlighted ERBB4 as a key regulator in pathogenesis.
  • In vivo experiments showed reduced inflammatory cell infiltration and enhanced collagen fiber contractility following ERBB4 knockdown.
  • ERBB4 silencing suppressed integrin-binding proteins and inhibited NF-κB signaling.
  • These findings suggest that ERBB4 is critical in the progression of aortic dissection.
  • Targeting ERBB4 may provide potential new treatment strategies for patients with aortic dissection.

Simplified

Key numbers

CCK-8 results revealed that cell viability was inhibited in the siERBB4 group compared to the siCtrl group (< 0.05).
Cell Viability Decrease
Comparison of cell viability between ERBB4 knockdown and control groups.
Inflammatory cell infiltration was reduced in the shERBB4 group compared to the shCtrl group (< 0.05).
Inflammatory Cell Infiltration Reduction
Comparison of inflammatory cell infiltration in aortic tissue between groups.
Masson staining showed a significant increase in the contractile strength of collagen fibers in the shERBB4 group compared to the shCtrl group (< 0.05).
Contractile Strength Improvement
Comparison of collagen fiber contractility between ERBB4 knockdown and control groups.

Full Text

What this is

  • This research investigates the role of ERBB4 in () and its potential as a therapeutic target.
  • ERBB4 is implicated in the phenotypic transition of () associated with .
  • The study employs various molecular biology techniques to assess the impact of ERBB4 knockdown on cell behavior and tissue pathology.

Essence

  • ERBB4 plays a critical role in progression by influencing vascular smooth muscle cell behavior. Knockdown of ERBB4 mitigates pathological changes in these cells and enhances vascular integrity.

Key takeaways

  • ERBB4 knockdown significantly inhibits human aortic smooth muscle cell (HASMC) viability, migration, and angiogenesis. This was demonstrated through various assays, including CCK-8 and tube formation assays.
  • In vivo studies showed that ERBB4 knockdown reduced inflammatory cell infiltration and improved collagen fiber contractility in aortic tissue. Masson staining indicated enhanced contractile strength of collagen fibers after ERBB4 suppression.
  • The underlying mechanisms involve the suppression of integrin-binding proteins and inhibition of NF-κB signaling. This suggests that ERBB4 modulates the pathological processes associated with .

Caveats

  • The long-term effects of ERBB4 on require further investigation due to the chronic nature of the condition.
  • Animal models may not fully replicate human , potentially limiting the applicability of these findings.
  • Consideration of delivery systems and potential off-target effects is necessary for the safety and efficacy of future ERBB4-targeted therapies.

Definitions

  • Aortic dissection (AD): A life-threatening condition where the inner layer of the aorta tears, leading to blood flow between the layers.
  • Vascular smooth muscle cells (VSMCs): Cells that make up the muscular layer of blood vessels, playing a key role in maintaining vascular tone and structure.

Simplified

Funding

Competing interests

Conflicts of interest: Authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free